THENA Capital is a London-based early-stage MedTech venture fund founded by Dr. Pamela Walker Geddes, Esther Reynal de St Michel Richardot, and Tatum Getty. The firm is built on the thesis that UK MedTech produces world-class science and clinical innovation but systematically lacks the specialist, commercially-minded, transatlantically-connected capital needed to scale. Fund I closed at ~$57M USD (£45M) in June 2026, anchored by the British Business Bank's Enterprise Capital Funds programme, making THENA the first all-female GP-led ECF-backed fund. The LP base is over 50% female, composed of healthcare leaders, pharma executives, specialist investors, operators, and family offices.
THENA backs early-stage UK MedTech companies across digital health platforms and fast-track medical devices, with a focus on validated technology addressing critical clinical needs in chronic conditions, women's health, oncology, mental health, and care delivery.
The fund targets companies with credible commercialisation pathways and the ambition to scale from UK origination into global, particularly US, markets. THENA provides hands-on commercialisation support and transatlantic go-to-market access as core value-add alongside capital.
THENA Capital Fund I reached final close at ~$57M USD (£45M) in June 2026, anchored by the British Business Bank's ECF programme. Additional LPs include healthcare leaders, pharma executives, specialist investors, operators, and family offices.
The fund will back approximately 25 early-stage companies with initial cheques of $500K–$1M at seed stage. Five companies have been backed in the first year of deployment: Plexāā (BLOOM⁴³), Salient Bio, Sanome, Heim, and Zonova.
Leadership
Dr. Pamela Walker Geddes is Founding General Partner. She holds a PhD in Medical Sciences and an Executive MBA from Oxford. She has led clinical trial and regulatory pathways, driven commercial launches in pharma and MedTech, managed institutional investments, and guided exits including trade sales, secondaries, and IPOs from both the operator and investor side.
Esther Reynal de St Michel Richardot is Founding Managing Partner. She holds an MBA from Oxford and brings over 15 years of experience backing and advising MedTech companies across the UK, Europe, and the US, with expertise in operational scaling, commercial partnerships, and venture deal-making.
Tatum Getty is Founding General Partner. She holds an MBA from USC and has a decade of experience driving commercial growth and US market expansion for consumer health brands, blending investment insight with operational execution across go-to-market strategy and customer acquisition.
Investment Strategy
THENA invests at seed stage with initial cheques of ~$635K–$1.27M USD (£500K–£1M) into approximately 25 companies across Fund I. The firm takes a hands-on approach to commercialisation, supporting portfolio companies through US market expansion, strategic partnership structuring, and exit readiness.
THENA's Fellows Network, composed of clinicians, industry experts, and operators built through the Future of HealthTech Hub community, contributes to diligence, unlocks commercial pathways, and provides domain expertise across the portfolio.
Notable Investments
info@thenacapital.com
Dr. Pamela Walker Geddes — Founding General Partner
Esther Reynal de St Michel Richardot — Founding Managing Partner
Tatum Getty — Founding General Partner
United Kingdom
